| Product Code: ETC7342098 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Greece Antimicrobial Resistance Market Overview |
3.1 Greece Country Macro Economic Indicators |
3.2 Greece Antimicrobial Resistance Market Revenues & Volume, 2021 & 2031F |
3.3 Greece Antimicrobial Resistance Market - Industry Life Cycle |
3.4 Greece Antimicrobial Resistance Market - Porter's Five Forces |
3.5 Greece Antimicrobial Resistance Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Greece Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Greece Antimicrobial Resistance Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 Greece Antimicrobial Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
4 Greece Antimicrobial Resistance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Greece |
4.2.2 Rising awareness about the consequences of antimicrobial resistance |
4.2.3 Government initiatives to promote responsible antimicrobial use |
4.3 Market Restraints |
4.3.1 High cost associated with developing and implementing new antimicrobial treatments |
4.3.2 Limited availability of effective antibiotics |
4.3.3 Lack of robust regulatory framework for antimicrobial stewardship |
5 Greece Antimicrobial Resistance Market Trends |
6 Greece Antimicrobial Resistance Market, By Types |
6.1 Greece Antimicrobial Resistance Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Greece Antimicrobial Resistance Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Greece Antimicrobial Resistance Market Revenues & Volume, By Complicated Urinary Tract Infections (cUTI), 2021- 2031F |
6.1.4 Greece Antimicrobial Resistance Market Revenues & Volume, By Blood stream infections, 2021- 2031F |
6.1.5 Greece Antimicrobial Resistance Market Revenues & Volume, By Acute bacterial skin and skin structure infections (ABSSSI), 2021- 2031F |
6.1.6 Greece Antimicrobial Resistance Market Revenues & Volume, By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), 2021- 2031F |
6.1.7 Greece Antimicrobial Resistance Market Revenues & Volume, By Community acquired pneumonia (CAP), 2021- 2031F |
6.1.8 Greece Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Greece Antimicrobial Resistance Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Greece Antimicrobial Resistance Market Revenues & Volume, By Combination therapies, 2021- 2031F |
6.2.3 Greece Antimicrobial Resistance Market Revenues & Volume, By Tetracyclines, 2021- 2031F |
6.2.4 Greece Antimicrobial Resistance Market Revenues & Volume, By Cephalosporins, 2021- 2031F |
6.2.5 Greece Antimicrobial Resistance Market Revenues & Volume, By Glycopeptides and Lipoglycopeptides, 2021- 2031F |
6.2.6 Greece Antimicrobial Resistance Market Revenues & Volume, By Oxazolidinones, 2021- 2031F |
6.2.7 Greece Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Greece Antimicrobial Resistance Market, By Mechanism of Action |
6.3.1 Overview and Analysis |
6.3.2 Greece Antimicrobial Resistance Market Revenues & Volume, By Protein Synthesis Inhibitors, 2021- 2031F |
6.3.3 Greece Antimicrobial Resistance Market Revenues & Volume, By Cell Wall Synthesis Inhibitors, 2021- 2031F |
6.3.4 Greece Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Greece Antimicrobial Resistance Market, By Pathogen |
6.4.1 Overview and Analysis |
6.4.2 Greece Antimicrobial Resistance Market Revenues & Volume, By Klebsiella pneumoniae, 2021- 2031F |
6.4.3 Greece Antimicrobial Resistance Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.4.4 Greece Antimicrobial Resistance Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.4.5 Greece Antimicrobial Resistance Market Revenues & Volume, By Enterococcus Spp, 2021- 2031F |
6.4.6 Greece Antimicrobial Resistance Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.4.7 Greece Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
7 Greece Antimicrobial Resistance Market Import-Export Trade Statistics |
7.1 Greece Antimicrobial Resistance Market Export to Major Countries |
7.2 Greece Antimicrobial Resistance Market Imports from Major Countries |
8 Greece Antimicrobial Resistance Market Key Performance Indicators |
8.1 Rate of antibiotic prescriptions in healthcare facilities |
8.2 Percentage of healthcare professionals trained in antimicrobial stewardship |
8.3 Number of reported cases of multidrug-resistant infections in Greece |
8.4 Investment in research and development of new antimicrobial agents |
8.5 Adoption rate of guidelines for antimicrobial stewardship in healthcare institutions |
9 Greece Antimicrobial Resistance Market - Opportunity Assessment |
9.1 Greece Antimicrobial Resistance Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Greece Antimicrobial Resistance Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Greece Antimicrobial Resistance Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.4 Greece Antimicrobial Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
10 Greece Antimicrobial Resistance Market - Competitive Landscape |
10.1 Greece Antimicrobial Resistance Market Revenue Share, By Companies, 2024 |
10.2 Greece Antimicrobial Resistance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here